Please wait...
About This Project
The high specificity and sensitivity of the CRISPR diagnostics, e.g. SHERLOCK, can detect the presence of the pathogen genome and report out the result accurately through the CRISPR-Cas system. It provides genome targeting based results and is superior to any serological based rapid test kits (RTKs). This project aims to improve the CRISPR diagnostic platform with an amplification-free approach, to enable a novel and robust RTK for SARS-COV2 detection.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Urban Pollination: sustain native bees & urban crops
Bee activity on our crop flowers is crucial to human food security, but bees are also declining around the...
Cannibalism in Giant Tyrannosaurs
This is the key question we hope to answer with this study. This project is to fund research into a skull...
Seattle HiveBio Community Lab
Thank you to everyone who has supported HiveBio thus far. As of April 17th we've reached our basic funding...